Please download the dossier by clicking on the dossier button x
×

Liquid preparation comprising pimobendan

  • US 10,639,305 B2
  • Filed: 02/27/2017
  • Issued: 05/05/2020
  • Est. Priority Date: 11/07/2006
  • Status: Active Grant
First Claim
Patent Images

1. A method of treatment of a disease or a condition in a subject in a need of such treatment, wherein the subject is a mammal, the method comprising:

  • administering to the subject in need of such treatment a liquid preparation comprising an etherified cyclodextrin derivative and pimobendan or a pharmaceutically acceptable salt thereof, wherein the etherified cyclodextrin derivative is selected from the group consisting of alpha-, beta, and gamma-cyclodextrin ether;

    wherein;

    the disease or the condition to be treated is selected from the group consisting of;

    congestive heart failure (CHF), acute CHF, decompensated endocardiosis (DCE), dilated cardiomyopathy (DCM), asymptomatic (occult) CHF, asymptomatic DCM, shock, gastric dilation, volvulus, myocardial ischemia, and renal ischemia; and

    the liquid preparation has a pH of 5.5 to 8.5.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×